Jaguar Health, Inc. (JAGX) Social Stream
JAGUAR HEALTH INC (JAGX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering JAGUAR HEALTH INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-21 | 2 | $15.001 | $13 | $14 | $0.119 | 11664.71% |
| 2021-11-18 | 1 | $6.75 | $5 | $5.875 | $0.119 | 4836.97% |
| 2022-08-23 | 2 | $6.75 | $5 | $5.875 | $0.119 | 4836.97% |
| 2022-10-06 | 1 | $225.563 | $225.563 | $225.563 | $0.119 | 189448.74% |
| 2022-11-15 | 2 | $5 | $3 | $4 | $0.119 | 3261.34% |
| 2023-01-17 | 2 | $225.563 | $150.375 | $187.969 | $0.119 | 157857.14% |
| 2023-05-23 | 1 | $6 | $6 | $6 | $0.119 | 4942.02% |
The Trend in the Analyst Price Target
JAGX's average price target has moved up $1.5 over the prior 23 months.
Over the past 126 days, JAGX's average upside potential has been 42,019.46%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-17 | 2 | 3.000 | 2.000 | 2.500 | 0.092 | 2617.39% |
| 2023-01-17 | 2 | 3.000 | 2.000 | 2.500 | 6.900 | -63.77% |
| 2023-01-17 | 2 | 225.563 | 150.375 | 187.969 | 0.092 | 204214.13% |
| 2023-01-17 | 2 | 225.563 | 150.375 | 187.969 | 6.900 | 2624.19% |
| 2023-05-23 | 1 | 6.000 | 6.000 | 6.000 | 0.745 | 705.37% |
JAGX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 52 weeks, JAGX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- JAGX has a higher upside potential (average analyst target price relative to current price) than 797.07% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, JAGUAR HEALTH INC's number of analysts covering the stock is greater than 14.15% of them.
- JAGUAR HEALTH INC's average analyst price target is greater than 250.46% of Pharmaceutical Products stocks.
- JAGX has a lower variance in analysts' estimates than -21% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, ACST, CANF, and BLRX are the three stocks most similar to JAGUAR HEALTH INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is JAGX a Buy, Hold or Sell? See the POWR Ratings now!